ZERODHAAMC - SILVERCASE (NSE: SILVERCASE, BSE: 544384) is a listed company in the Mutual Fund Scheme industry. With a market capitalisation of ₹0 Cr, it ranks #6,186 by market cap among the 6,197 Indian listed companies on FinBizNet, and #112 of 115 in Mutual Fund Scheme. At ₹17.84 (as of 16 Nov 2026), the share price is 53.1% below its 52-week high of ₹38.01 and 16.4% above its 52-week low of ₹15.33. The share price is up 18.6% over one year and down 24.0% over three months.
| Current Price | ₹17.84 |
|---|---|
| Market Cap | ₹0 Cr |
| NSE Symbol | SILVERCASE |
| BSE Code | 544384 |
| Sector | Financials > Financial Services > Capital Markets |
| Sub-Industry | Mutual Fund Scheme |
| 52-Week Range | ₹15.33 – ₹38.01 |
| 1-Year Price Change | +18.6% |
| 3-Month Price Change | -24.0% |
| Beta (1Y) | 1.02 |
Delivery averaged 41.0% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).
1. NA-NA 2. NA-NA 3. NA-NA 4. NA-NA
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| EDELAMC - ENIFTY | ₹16 Cr | — | — | — | — |
| BANDHANAMC - SILVERBND | ₹10 Cr | — | — | — | — |
| GROWWAMC - GROWWCAPM | ₹8 Cr | — | — | — | — |
| KOTAKMAMC - CHEMICAL | ₹7 Cr | — | — | — | — |
| MOTILALAMC - MOMNC | ₹5 Cr | — | — | — | — |
| MOTILALAMC - MOPSE | ₹5 Cr | — | — | — | -1.7% |
| MOTILALAMC - MOTOUR | ₹5 Cr | — | — | — | -4.0% |
| ZERODHAAMC - SILVERCASE | ₹0 Cr | — | — | — | +18.6% |
| 360ONEAMC - GOLD360 | ₹0 Cr | — | — | — | +56.7% |
Listed by market capitalisation. Ratios are shown for context only.
ZERODHAAMC - SILVERCASE is trading at ₹17.84, with a market capitalisation of ₹0 Cr.
ZERODHAAMC - SILVERCASE operates in the Financials > Financial Services > Capital Markets space (Mutual Fund Scheme).
ZERODHAAMC - SILVERCASE is listed on the NSE under the symbol SILVERCASE and on the BSE under the scrip code 544384.
ZERODHAAMC - SILVERCASE's share price is up 18.6% over one year and down 24.0% over three months. Its 52-week range is ₹15.33 to ₹38.01.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.